M&A Deal Summary

Exact Sciences Acquires PreventionGenetics

On January 9, 2022, Exact Sciences acquired life science company PreventionGenetics for 190M USD

Acquisition Highlights
  • This is Exact Sciences’ 6th transaction in the Life Science sector.
  • This is Exact Sciences’ 3rd largest (disclosed) transaction.
  • This is Exact Sciences’ 7th transaction in the United States.
  • This is Exact Sciences’ 1st transaction in Wisconsin.

M&A Deal Summary
Date 2022-01-09
Target PreventionGenetics
Sector Life Science
Buyer(s) Exact Sciences
Deal Type Add-on Acquisition
Deal Value 190M USD
Advisor(s) Crosstree Capital Partners, Inc. (Financial)
Winston & Strawn (Legal)

Target

PreventionGenetics

Marshfield, Wisconsin, United States
website
PreventionGenetics provides the clinical lab, expertise, and foundational technology necessary to accelerate the availability of HCT and help more patients know their germline risk of cancer and other diseases. PreventionGenetics was founded in 2004 and is based in Marshfield, Wisconsin.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Exact Sciences

Madison, Wisconsin, United States

website

Category Company
Founded 1995
Sector Life Science
Employees6,420
Revenue 1.8B USD (2021)
DESCRIPTION

Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Exact Sciences was founded in 1995 and is based in Madison, Wisconsin.

DEAL STATS #
Overall 8 of 8
Sector (Life Science) 6 of 6
Type (Add-on Acquisition) 7 of 7
State (Wisconsin) 1 of 1
Country (United States) 7 of 7
Year (2022) 1 of 1
Size (of disclosed) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-16 Ashion Analytics

Phoenix, Arizona, United States

Ashion Analytics is a clinical genomics testing company dedicated to accelerating the use of genomic information to help doctors provide patients with the right treatment for their disease. Ashion Analytics LLC was founded in 2014 and is based in Phoenix, Arizona.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-02 Exact Sciences - DX GPS Prostate Cancer Business

Madison, Wisconsin, United States

Exact Sciences's DX GPS Prostate Cancer Business is a broadly commercialized and clinically validated test available today across the urology community. Exact Sciences's DX GPS Prostate Cancer Business is based in Madison, Wisconsin.

Sell $100M
Mergr

Product

Company

Legal